Skip to main content

Animations

MJFF Publications

4401 - 4410 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2024
  • 2024
  • 2024
  • 2022
  • 2022
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
    Journal Name: Genome Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13073-022-01132-9
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29220
    Citation Count: 21
  • Summary Details
    OPEN
    Title: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies
    Journal Name: Nature Biomedical Engineering
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41551-024-01242-2
    Citation Count: 13
  • Summary Details
    OPEN
    Title: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-52298-2
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer
    Journal Name: Nature Metabolism
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42255-024-01118-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00409-5
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Cognitive dysfunction 1 year after COVID‐19: evidence from eye tracking
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51675
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-53168-7
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.